{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:25:49Z","timestamp":1790623549975,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/npp.2013.128","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T09:48:01Z","timestamp":1368784081000},"page":"2268-2277","source":"Crossref","is-referenced-by-count":230,"title":["GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine"],"prefix":"10.1038","volume":"38","author":[{"given":"Rong-Jian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Fuchikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E","family":"Lepack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"BFnpp2013128_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000). Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351\u2013354.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013128_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrn1846","volume":"7","author":"O Berton","year":"2006","unstructured":"Berton O, Nestler EJ (2006). New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7: 137\u2013151.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2013128_CR3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/mp.2011.47","volume":"16","author":"E Beurel","year":"2011","unstructured":"Beurel E, Song L, Jope RS (2011). Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16: 1068\u20131070.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2013128_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnmol.2012.00013","volume":"5","author":"CA Bradley","year":"2012","unstructured":"Bradley CA, Peineau S, Taghibiglou C, Nicolas CS, Whitcomb DJ, Bortolotto ZA et al (2012). A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci 5: 13.","journal-title":"Front Mol Neurosci"},{"key":"BFnpp2013128_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrn2867","volume":"11","author":"GL Collingridge","year":"2010","unstructured":"Collingridge GL, Peineau S, Howland JG, Wang YT (2010). Long-term depression in the CNS. Nat Rev Neurosci 11: 459\u2013473.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp2013128_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.toxlet.2008.08.012","volume":"182","author":"J Deguil","year":"2008","unstructured":"Deguil J, Perault-Pochat MC, Chavant F, Lafay-Chebassier C, Fauconneau B, Pain S (2008). Activation of the protein p7OS6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain. Toxicol Lett 182: 91\u201396.","journal-title":"Toxicol Lett"},{"key":"BFnpp2013128_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","volume":"67","author":"N Diazgranados","year":"2010","unstructured":"Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S et al (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67: 793\u2013802.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013128_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1126\/science.1222939","volume":"338","author":"RS Duman","year":"2012","unstructured":"Duman RS, Aghajanian GK (2012). Synaptic dysfunction in depression: potential therapeutic targets. Science 338: 68\u201372.","journal-title":"Science"},{"key":"BFnpp2013128_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jad.2008.10.014","volume":"116","author":"A Fekadu","year":"2009","unstructured":"Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ (2009). What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 116: 4\u201311.","journal-title":"J Affect Disord"},{"key":"BFnpp2013128_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnmol.2012.00014","volume":"5","author":"L Freland","year":"2012","unstructured":"Freland L, Beaulieu JM (2012). Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci 5: 14.","journal-title":"Front Mol Neurosci"},{"key":"BFnpp2013128_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0269881109104845","volume":"24","author":"M Ghasemi","year":"2010","unstructured":"Ghasemi M, Raza M, Dehpour AR (2010). NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test. J Psychopharmacol 24: 585\u2013594.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2013128_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1017\/S1461145704004535","volume":"7","author":"TD Gould","year":"2004","unstructured":"Gould TD, Einat H, Bhat R, Manji HK (2004). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7: 387\u2013390.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2013128_CR13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/sj.npp.1300731","volume":"30","author":"TD Gould","year":"2005","unstructured":"Gould TD, Manji HK (2005). Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30: 1223\u20131237.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013128_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","volume":"33","author":"CA Hoeffer","year":"2010","unstructured":"Hoeffer CA, Klann E (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33: 67\u201375.","journal-title":"Trends Neurosci"},{"key":"BFnpp2013128_CR15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","volume":"35","author":"CS Jernigan","year":"2011","unstructured":"Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA et al (2011). The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35: 1774\u20131779.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2013128_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnmol.2011.00016","volume":"4","author":"RS Jope","year":"2011","unstructured":"Jope RS (2011). Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci 4: 16.","journal-title":"Front Mol Neurosci"},{"key":"BFnpp2013128_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.biopsych.2004.01.008","volume":"55","author":"O Kaidanovich-Beilin","year":"2004","unstructured":"Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004). Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55: 781\u2013784.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013128_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","volume":"4","author":"O Kaidanovich-Beilin","year":"2011","unstructured":"Kaidanovich-Beilin O, Woodgett JR (2011). GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci 4: 40.","journal-title":"Front Mol Neurosci"},{"key":"BFnpp2013128_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/nm.2886","volume":"18","author":"HJ Kang","year":"2012","unstructured":"Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P et al (2012). Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 18: 1413\u20131417.","journal-title":"Nat Med"},{"key":"BFnpp2013128_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0896-6273(03)00598-1","volume":"40","author":"EK Lambe","year":"2003","unstructured":"Lambe EK, Aghajanian GK (2003). Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40: 139\u2013150.","journal-title":"Neuron"},{"key":"BFnpp2013128_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959\u2013964.","journal-title":"Science"},{"key":"BFnpp2013128_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","volume":"69","author":"N Li","year":"2011","unstructured":"Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H et al (2011). Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69: 754\u2013761.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013128_CR23","first-page":"167","volume":"80","author":"A Little","year":"2009","unstructured":"Little A (2009). Treatment-resistant depression. Am Fam Physician 80: 167\u2013172.","journal-title":"Am Fam Physician"},{"key":"BFnpp2013128_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1073\/pnas.0706679105","volume":"105","author":"RJ Liu","year":"2008","unstructured":"Liu RJ, Aghajanian GK (2008). Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci USA 105: 359\u2013364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2013128_CR25","doi-asserted-by":"publisher","first-page":"e56053","DOI":"10.1371\/journal.pone.0056053","volume":"8","author":"XC Ma","year":"2013","unstructured":"Ma XC, Dang YH, Jia M, Ma R, Wang F, Wu J et al (2013). Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS One 8: e56053.","journal-title":"PLoS One"},{"key":"BFnpp2013128_CR26","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/da.20540","volume":"25","author":"SJ Mathew","year":"2008","unstructured":"Mathew SJ (2008). Treatment-resistant depression: recent developments and future directions. Depress Anxiety 25: 989\u2013992.","journal-title":"Depress Anxiety"},{"key":"BFnpp2013128_CR27","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/npp.2010.43","volume":"35","author":"A Polter","year":"2010","unstructured":"Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA et al (2010). Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 35: 1761\u20131774.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013128_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000314310","volume":"62","author":"JA Quiroz","year":"2010","unstructured":"Quiroz JA, Machado-Vieira R, Zarate CA Jr, Manji HK (2010). Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62: 50\u201360.","journal-title":"Neuropsychobiology"},{"key":"BFnpp2013128_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.conb.2009.05.013","volume":"19","author":"Y Yoshihara","year":"2009","unstructured":"Yoshihara Y, De Roo M, Muller D (2009). Dendritic spine formation and stabilization. Curr Opin Neurobiol 19: 146\u2013153.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp2013128_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","volume":"71","author":"CA Zarate Jr","year":"2011","unstructured":"Zarate CA Jr, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A et al (2011). Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 71: 939\u2013946.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013128_CR31","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856\u2013864.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013128_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21\u201335.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013128","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:44:38Z","timestamp":1684453478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFnpp2013128"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.128","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}